155 related articles for article (PubMed ID: 12799758)
1. Treatment of transient bone marrow oedema of the hip--a comparative study.
Radke S; Kirschner S; Seipel V; Rader C; Eulert J
Int Orthop; 2003; 27(3):149-52. PubMed ID: 12799758
[TBL] [Abstract][Full Text] [Related]
2. Transient marrow edema syndrome of the hip: results after core decompression. A prospective MRI-controlled study in 22 patients.
Radke S; Rader C; Kenn W; Kirschner S; Walther M; Eulert J
Arch Orthop Trauma Surg; 2003 Jun; 123(5):223-7. PubMed ID: 12739033
[TBL] [Abstract][Full Text] [Related]
3. [MRI-controlled outcome after core decompression of the femur head in aseptic osteonecrosis and transient bone marrow edema].
Wirtz C; Zilkens KW; Adam G; Niethard FU
Z Orthop Ihre Grenzgeb; 1998; 136(2):138-46. PubMed ID: 9615976
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of intravenous iloprost therapy in patients with bone marrow oedema of the hip.
Zippelius T; Perka C; Preininger B; Matziolis G; Strube P; Röhner E
Acta Orthop Belg; 2018 Jun; 84(2):172-178. PubMed ID: 30462600
[TBL] [Abstract][Full Text] [Related]
5. The management of necrosis-associated and idiopathic bone-marrow oedema of the proximal femur by intravenous iloprost.
Disch AC; Matziolis G; Perka C
J Bone Joint Surg Br; 2005 Apr; 87(4):560-4. PubMed ID: 15795211
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of long-term nonsteroidal antiinflammatory drug treatment on magnetic resonance imaging-determined bone marrow oedema in early, active axial spondyloarthritis patients.
Tang M; Xue L; Shen Y; Bo L; Yang R; Wen J; Zhang Y; Liu Z; Fu J
Clin Rheumatol; 2018 Jan; 37(1):245-250. PubMed ID: 28497237
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of autologous stem cell therapy in femoral head avascular necrosis: a comparative study.
Ulusoy İ; Yılmaz M; Kıvrak A
J Orthop Surg Res; 2023 Oct; 18(1):799. PubMed ID: 37875891
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow edema syndrome of the femoral head: treatment with the prostacyclin analogue iloprost vs. core decompression: an MRI-controlled study.
Aigner N; Petje G; Schneider W; Meizer R; Wlk M; Kotsaris S; Knahr K; Landsiedl F
Wien Klin Wochenschr; 2005 Feb; 117(4):130-5. PubMed ID: 15847192
[TBL] [Abstract][Full Text] [Related]
9. Autologous bone marrow-derived CD133 cells with core decompression as a novel treatment method for femoral head osteonecrosis: a pilot study.
Emadedin M; Karimi S; Karimi A; Labibzadeh N; Niknejadi M; Baharvand H; Aghdami N
Cytotherapy; 2019 Jan; 21(1):107-112. PubMed ID: 30409698
[TBL] [Abstract][Full Text] [Related]
10. Coexistent lumbar spine disorders have a crucial impact on the clinical outcome after total hip replacement.
Ellenrieder M; Bader R; Bergschmidt P; Fröhlich S; Mittelmeier W
J Orthop Sci; 2015 Nov; 20(6):1046-52. PubMed ID: 26286679
[TBL] [Abstract][Full Text] [Related]
11. [Comprehensive management of early stage avascular necrosis of femoral head by arthroscopic minimally invasive surgery].
Zhuo N; Wan Y; Lu X; Zhang Z; Tan M; Chen G
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Sep; 26(9):1041-4. PubMed ID: 23057342
[TBL] [Abstract][Full Text] [Related]
12. [Early results of autologous mononuclear bone marrow cell implantation in nontraumatic avascular necrosis of the femoral head].
Karatoprak O; Korkmaz MF; Kara AN; Göğüş A; Işiklar ZU
Acta Orthop Traumatol Turc; 2008; 42(3):178-83. PubMed ID: 18716432
[TBL] [Abstract][Full Text] [Related]
13. Efficiency of iloprost treatment for osseous malperfusion.
Jäger M; Zilkens C; Bittersohl B; Matheney T; Kozina G; Blondin D; Krauspe R
Int Orthop; 2011 May; 35(5):761-5. PubMed ID: 20306261
[TBL] [Abstract][Full Text] [Related]
14. Treatment of sickle cell disease's hip necrosis by core decompression: a prospective case-control study.
Mukisi-Mukaza M; Manicom O; Alexis C; Bashoun K; Donkerwolcke M; Burny F
Orthop Traumatol Surg Res; 2009 Nov; 95(7):498-504. PubMed ID: 19801210
[TBL] [Abstract][Full Text] [Related]
15. Transient bone marrow oedema of the foot.
Radke S; Vispo-Seara J; Walther M; Ettl V; Eulert J
Int Orthop; 2001; 25(4):263-7. PubMed ID: 11561506
[TBL] [Abstract][Full Text] [Related]
16. Bone-marrow oedema syndrome and transient osteoporosis of the hip. An MRI-controlled study of treatment by core decompression.
Hofmann S; Engel A; Neuhold A; Leder K; Kramer J; Plenk H
J Bone Joint Surg Br; 1993 Mar; 75(2):210-6. PubMed ID: 8444939
[TBL] [Abstract][Full Text] [Related]
17. Combining Concentrated Autologous Bone Marrow Stem Cells Injection With Core Decompression Improves Outcome for Patients with Early-Stage Osteonecrosis of the Femoral Head: A Comparative Study.
Tabatabaee RM; Saberi S; Parvizi J; Mortazavi SM; Farzan M
J Arthroplasty; 2015 Sep; 30(9 Suppl):11-5. PubMed ID: 26143238
[TBL] [Abstract][Full Text] [Related]
18. Natural course of intra-articular shifting bone marrow edema syndrome of the knee.
Aigner N; Meizer R; Petje G; Meizer E; Abdelkafy A; Landsiedl F
BMC Musculoskelet Disord; 2008 Apr; 9():45. PubMed ID: 18405354
[TBL] [Abstract][Full Text] [Related]
19. Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein.
Lieberman JR; Conduah A; Urist MR
Clin Orthop Relat Res; 2004 Dec; (429):139-45. PubMed ID: 15577478
[TBL] [Abstract][Full Text] [Related]
20. Juvenile bone-marrow oedema of the acetabulum treated by iloprost.
Aigner N; Petje G; Schneider W; Krasny C; Grill F; Landsiedl F
J Bone Joint Surg Br; 2002 Sep; 84(7):1050-2. PubMed ID: 12358371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
